Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ioka

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1997
[Study of hemostatic molecular marker]H Wada, M Ioka
Neuroscience Letters|July 11, 2001
Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouseM Narita, S Ozaki, M Ioka, et al.
Neuroscience|August 3, 2001
Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouseM Narita, S Ozaki, M Ioka, et al.
American Journal of Hematology|July 14, 1998
Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuriesH Wada, Y Mori, M Shimura, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1997
[Study of hemostatic molecular marker]H Wada, M Ioka
Neuroscience Letters|July 11, 2001
Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouseM Narita, S Ozaki, M Ioka, et al.
Neuroscience|August 3, 2001
Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouseM Narita, S Ozaki, M Ioka, et al.
American Journal of Hematology|July 14, 1998
Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuriesH Wada, Y Mori, M Shimura, et al.
Pageof 1